おかえりなさい
アカウント登録
siteでログインする
siteで登録する
受信トレイを確認する
BioMotiv
About
BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $25M
- Industries
- Biotechnology,Life Science,Medical,Therapeutics
- Founded date
- Jan 1, 2012
- Number Of Employee
- 11 - 50
- Operating Status
- Active
- Investor Type
- Accelerate
BioMotiv is a therapeutic accelerator developing a portfolio of novel medicines. BioMotiv is the mission-aligned development company of The Harrington Project for Discovery and Development. The Harrington Project, unveiled in February by University Hospitals (UH), is a first-of-its-kind $250 million initiative that promises to revolutionize how new breakthrough drugs are advanced to market. By aligning the upstream efforts of the recently created UH Case Medical Center’s Harrington Discovery Institute with the downstream development efforts of BioMotiv, The Harrington Project seeks to accelerate the therapeutic innovation process for the benefit of patients globally.The company was founded in 2012 and is headquartered in Cleveland, Ohio.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 5, 2013 | Series Unknown | $25M | 2 |
Nationwide Mutual Capital
|
— | Detail |
| Sep 5, 2012 | Series Unknown | $81.42M | 1 |
|
— | Detail |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Mar 17, 2021
Amphista Therapeutics
|
Series B | $53M | Biopharma | — |
|
Apr 7, 2020
Amphista Therapeutics
|
Series A | $7.50M | Biopharma | — |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Nationwide Mutual Capital
|
Yes | Series Unknown |
|
|
— | Series Unknown |
